ptg-300
protagonist therapuetics
['mpnsm', 'revive', '#mpn', 'protagonisttx', 'protagonist therap']
#polycythemiavera (pv) patients need to maintain a hematocrit of &lt;45% to reduce the incidence of thrombosis. learn more in our #eha2022 abstract on the revive study data, which can be viewed on the conference website until august 15th, 2022. #mpnsm
Discovering and developing novel therapies through our proprietary technology platform. #biotech #lifesciences #innovation